| October 22nd – Morning Hosted by：Arsalan Arif, ENDPOINTS NEWS, CEO |
||
|---|---|---|
| 09:00 | Chairperson Opening - John Oyler | John Oyler (BeiGene - Founder & CEO) |
| 09:20 | Chairperson Opening - Samantha Du | Samantha Du (Zai Lab - Chairman & CEO) |
| 09:40 | Editor's Keynote: The US-China biopharma world has arrived | John Carroll (Endpoints News - Founder & Editor) |
| 10:00 | Keynote 2: China's biopharma industry: A brief history and new beginnings | Mingde Yu (Chinese Pharmaceutical Enterprises Association - Chairman) |
| 10:30 | Keynote 3: The US biopharma venture landscape and lessons for Chinese ventures | Fred Cohen (Vida Ventures - Co-Founder and Sr. Managing Director) |
| 11:00 | Coffee Break | |
| 11:10 | Keynote 4: Chinese innovation from the eyes of an investor | Nisa Leung, Qiming Venture, Managing Partner |
| 11:35 | Keynote 5: Making a successful launch strategy for Chinese biopharma | Michael Yu, Innovent Biologics, Founder & Chairman |
| 12:00 | Fireside chat: John Carroll and Faheem Hasnain | Faheem Hasnain, Gossamer Bio, Co-Founder |
| 12:00 | Lunch Buffet | |
| October 22nd – Afternoon Hosted by：Liyun Zhou (Pharmcube - Chairman) |
||
|---|---|---|
| 13:30 | Data Stories: China's innovation in the global biopharma landscape - unveiling China pipelines and cross-border transactions | Jianhua Jiang (Pharmcube - CEO) |
| Session 1: Innovation | ||
| 13:50 | Panel 1: Opportunities from the biopharma R&D “gap” |
MODERATOR: John Carroll (Endpoints News - Editor-in-chief) PANELISTS: Lianshan Zhang (Hengrui Pharma - President, Global R&D) Weiguo Su (Chi-Med - Executive Director&CSO) Shuqian Jing (Gmax Biopharm - Founder Chairman&CEO) Zicai Liang (Ribo Life Science - Founder&Chairman) George Syrmalis (The iQ Group Global - Founder and Group CEO) |
| roadshow | ||
| 14:30 | Demand is priority: From capability orientation to demand orientation | Jing Qiang (Apricot Capital - Managing Partner, Sinovent - Chairman) |
| 14:45 | GPCR antibody drugs: Clinical value and development challenges | Shuqian Jing (Gmax Biopharm - Founder Chairman & CEO) |
| 15:00 | Panel 2: How do Chinese biotechs differentiate themselves in the domestic and global market? |
MODERATOR: Roger Liu (Renowned industry writer, AstraZeneca, VP) PANELISTS: Dajun Yang (Ascentage Pharma - Founder&Chairman) Guoliang Yu (CBT Pharmaceuticals - Founder) Li Chen (Hua Medicine - Founder and CEO) Xiao Xu (ACEA Bioscience - CEO) William Liang (Zai Lab- CCO) |
| 15:40 | Coffee Break | |
| 15:50 | Panel 3: New technology, new mindset and the Chinese oncology pipeline |
MODERATOR: Yuli Xie (Ouling Bio-Medicine - CEO) PANELISTS: John Connolly (Tessa Therapeutics - CSO) Jay Mei (Antengene Corporation - Founder&CEO) Yaochang Xu (Abbisko Therapeutics - Founder&President) Weichang Zhou (WuXi Biologics - CTO, Sr. VP) James Yan (Zai Lab - Executive VP) |
| Session 2: Cross-border Transaction | ||
| 16:30 | Panel 1: Best — and worst — approaches to finding a partner and inking a deal in China |
MODERATOR: Jimmy Zhang (Lilly Aisa Ventures - Venture Partner) PANELISTS: Bing Yuan (Cstone Pharmaceuticals - Chief Business Officer) Carsten Lu (Adlai Nortye - Chairman & CEO) Mike Liu (Alphamab - Executive VP) Yan Song (Link Health Group - CEO) |
| 17:00 | Panel 2: The US perspective: What do US execs want from China deals? |
MODERATOR: Arsalan Arif (ENDPOINTS NEWS - CEO) PANELISTS: Faheem Hasnain (Gossamer Bio - co-Founder) Micah Mackison (Assembly Biosciences - Sr. VP) Chris Xiangyang Lu (Laekna Therapeutics - Founder&CEO) Patrick Gallagher (Aquilo Partners - Principal) |
| 17:30 | Cocktail Reception Hosted by WSFG |
PR considerations for biotech IPOs Koko Ku (WSFG, Partner) How to run a successful biotech IPO Kenneth Sun (Morgan Stanley - Executive Director) |
| 18:30 | Gala Dinner Hosted by GBSG | |
| October 23rd – Morning Hosted by：Arsalan Arif, Endpoints News, CEO |
||
|---|---|---|
| 09:00 | Chairman opening by Leon Chen | Leon Chen (6Dimensions - CEO & Founding Partner) |
| 09:15 | Keynote 6: History and outlook on China's biopharma investment | Jonathan Wang, OrbiMed Asia, Founding Partner & Sr. Managing Director |
| 10:00 | Keynote 7: A look at the "Major drug development program" and China's innovative new drugs | Jinhui Gu, National Health Commission, Director, Office of Major Drug Development |
| 10:30 | Keynote 8: Rise of China biopharma and its unique dynamics -- a US perspective | Brad Loncar, Loncar Investment, Founder |
| 11:00 | Coffee Break | |
| 11:10 | Keynote 9: The new rules for listing on HKEX and updates on its implementation | Natalie Chen, HKEX, Assistant VP |
| 11:35 | Keynote: Vivek Ramaswamy | Vivek Ramaswamy, Roivant Sciences, Founder & CEO |
| 12:00 | Fireside chat: John Carroll and Vivek Ramaswamy on talent, dealmaking, and exits | Vivek Ramaswamy, Roivant Science, Founder |
| 12:30 | Lunch Buffet | |
| October 23nd – Afternoon Hosted by：Liyun Zhou (Pharmcube - Chairman) |
||
|---|---|---|
| Session 3: Biotech Investment and Exit | ||
| 13:30 | Panel 1: Inside the minds of China's top biopharma investment firms |
MODERATOR: Jean Cheng (Pharmcube -COO) PANELISTS: Erdong Hua (6Dimensions - Partner) Will Liu (8 Roads Ventures - Partner) Jing Qiang (Apricot Capital - CIO, Managing Partner) Quanhong Yuan (Shanghai Jianxin Capital - Founding Partner&President) Neo Zhang (C-Bridge Capital, Managing Director) |
| roadshow | ||
| 14:10 | Investing in drug discovery start-ups | Leo Leng (Legend Star Partner - Healthcare) |
| 14:25 | Innovative healthcare company investment from a global perspective | Karen Liu (3e Bioventures - Partner) |
| 14:40 | Panel 2: US biotech financing trends and implications for Chinese ventures |
MODERATOR: John Carroll, (ENDPOINTS NEWS - Editor-in-chief) PANELISTS: Alfred Scheidegger (Nextech Invest - Founding Partner) Vivek Ramaswamy (Roivant Science - Founder) Yining Zhao (Just Biotherapeutics - Founder & President) Lu Huang (Morningside VC - Managing Director) Cyber Cao (Sequoia Capital China - Managing Director |
| 15:20 | Panel 3: IPOs — China and the US |
MODERATOR: Arsalan Arif (ENDPOINTS NEWS - CEO) PANELISTS: Faheem Hasnain (Gossamer Bio - Co-Founder) Wenseng Wendy Pan (Sidley Austin - Partner) Jin Liang (CICC, Growth Enterprise IBD Executive Director, Head of Healthcare) Zidong Zhang (Henlius - CFO) Jielun Zhu (i-Mab Biopharma - CFO) |
| 16:00 | Coffee Break | |
| Session 4: Talent Challenge | ||
| 16:10 | Panel: Attracting Top Talent in a Competitive Innovation Market |
MODERATOR: Grace Lu (Russell Reynolds - Executive Director) PANELISTS: Alan Xu (J&J APAC Innovation Center - HR Head) Jeans Qian (dMed Biopharmaceutical - VP, HR & Operation) William Liang (Zai Lab - CCO) Chelsea Zhang (Ping An Ventures - Partner) |
| Session 5: Spotlight on New Technology | ||
| 16:40 | Panel 1: Gene editing — a special focus on leading programs |
MODERATOR: Cindy Ru (CRC Oncology Corp - Managing Directo) PANELISTS: Qiushi Li (CureGentics - COO) Dong Wei (EdiGene - CEO) Xiaodong Song (Hrain Biotechnology - Vice GM) Chien-Shing Chen (JiahuiHealth Cancer Center - Executive Director) |
| 17:10 | 2018 was a transformational year. What next? | ENDPOINTS NEWS & Pharmcube |
Rising high above the Pudong Lujiazui business district, this art-deco–inspired Hotel sits in the gleaming 21st Century Tower, surrounded by iconic skyscrapers and bustling city streets lined with luxury shopping, restaurants and prestigious financial centres.
